Œ¤‹†ƒe[ƒ}

‹ÆÑ

 

—ߘa1”N“x

 
Šwp
k•½¬31”N(2019”N)1ŒŽ1“ú`12ŒŽ31“úl
(’˜‘)
‡V ŒãŠá•”Ž¾Š³ i1j–Ô–ŒEÉŽq‘ÌŽ¾Š³ CDŽü•Ó–Ô–ŒCÉŽq‘ÌŽ¾Š³ 4.uveal effusion
•û“Þ•ÛŽq
Šá‰ÈŽ¾Š³ÅV‚ÌŽ¡—Ã2019-2021
234-235, “ì]“° 2019”N3ŒŽ25“ú”­s

4.ŽÎŽ‹ Še˜_ 9jÇŒóŒQ i2jƒƒrƒEƒXÇŒóŒQ
¼’q
ŠáŽ¾Š³ƒAƒgƒ‰ƒXƒVƒŠ[ƒY ŠOŠá•”ƒAƒgƒ‰ƒX
336-337, ‘‡ˆãŠwŽÐ 2019”N10ŒŽ”­s

“ÁW ‚—îŽÒ‚ƊᎾŠ³@‰Á—”Á•Ï«
•û“Þ•ÛŽq
Pharma Medica vol.37 No.12,
39-42, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ 2019”N12ŒŽ”­s

(‘à)
“œ”A•a‰©”Á•‚Žî‚ÌŽ¡—Ö¨ Trend Therapy for Diabetic Macular Edema
•û“Þ•ÛŽq
“ú–{Šá‰ÈŠw‰ïŽGŽ 123 (2): 99-100,2019

(Œ´’˜)
‰p•¶
Clinical characteristics and outcomes of open globe injuries in Japan.
Okamoto Y, Morikawa S, Okamoto F, Inomoto N, Ishikawa H, Ueda T, Sakamoto T, Sugitani K, Oshika T.
Jpn J Ophthalmol. 2019 Jan;63(1):109-118. doi: 10.1007/s10384-018-0638-x.

Diminished circadian blood pressure variability in elderly individuals with nuclear cataracts: cross-sectional analysis in the HEIJO-KYO cohort.
Yoshikawa T, Obayashi K, Miyata K, Nishi T, Ueda T, Kurumatani N, Saeki K, Ogata N.
Hypertens Res. 2019 Feb;42(2):204-210. doi: 10.1038/s41440-018-0140-3.

Effects of concentration of amyloid ƒÀ (AƒÀ) on viability of cultured retinal pigment epithelial cells.
Masuda N, Tsujinaka H, Hirai H, Yamashita M, Ueda T, Ogata N.
BMC Ophthalmol. 2019 Mar 8;19(1):70. doi: 10.1186/s12886-019-1076-3.

Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan.
Sugimoto M, Tsukitome H, Okamoto F, Oshika T, Ueda T, Niki M, Mitamura Y, Ishikawa H, Gomi F, Kitano S, Noma H, Shimura M, Sonoda S, Sawada O, Ohji M, Harimoto K, Takeuchi M, Takamura Y, Kondo M, Sakamoto T.
J Diabetes Investig. 2019 Mar;10(2):475-483. doi: 10.1111/jdi.12929.

Association between glaucomatous optic disc and depressive symptoms independent of light exposure profiles: a cross-sectional study of the HEIJO-KYO cohort.
Yoshikawa T, Obayashi K, Miyata K, Ueda T, Kurumatani N, Saeki K, Ogata N.
Br J Ophthalmol. 2019 Aug;103(8):1119-1122. doi: 10.1136/bjophthalmol-2018-312176.

Cataracts and Subclinical Carotid Atherosclerosis in Older Adults@\ A Cross-Sectional Study of the HEIJO-KYO Cohort \
Yoshikawa T, Obayashi K, Miyata K, Nishi T, Ueda T, Kurumatani N, Saeki K, Ogata N.
Circ J. 2019 Sep 25;83(10):2044-2048. doi: 10.1253/circj.CJ-19-0118.

Increased Nighttime Blood Pressure in Patients with Glaucoma: Cross-sectional Analysis of the LIGHT Study.
Yoshikawa T, Obayashi K, Miyata K, Saeki K, Ogata N.
Ophthalmology. 2019 Oct;126(10):1366-1371. doi: 10.1016/j.ophtha.2019.05.019.

Surgical Outcomes of Vitrectomy for Macular Hole Retinal Detachment in Highly Myopic Eyes: A Multicenter Study.
Kakinoki M, Araki T, Iwasaki M, Ueda T, Sano H, Hirano Y, Moriya Y, Sawada O, Takamura Y, Sakamoto T, Kanda T, Ohji M; Japan Clinical Retinal Study Team.
Ophthalmol Retina. 2019 Oct;3(10):874-878. doi: 10.1016/j.oret.2019.04.026.

Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K, Someya H, Yokoyama H, Takamura Y, Morioka M, Sameshima S, Ueda T, Kitano S, Tashiro M, Sugimoto M, Kondo M, Sakamoto T, Takeuchi M.
Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6.

Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Takayama K, Someya H, Yokoyama H, Kimura T, Takamura Y, Morioka M, Sameshima S, Ueda T, Ogata N, Kitano S, Tashiro M, Sugimoto M, Kondo M, Sakamoto T, Takeuchi M.
Acta Ophthalmol. 2019 Nov 1. doi: 10.1111/aos.14292. [Epub ahead of print]

Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study.
Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, Kokado M, Kogo J, Sasaki M, Morizane Y, Kotake O, Koto T, Sonoda S, Hirano T, Ishikawa H, Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Sugimoto M, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi K, Tsujinaka H, Kusuhara S, Kondo M, Takagi H, Murata T, Sakamoto T; Japan Clinical Retina Study (J-CREST) group.
Br J Ophthalmol. 2019 Nov 29. pii: bjophthalmol-2019-315199.
doi: 10.1136/bjophthalmol-2019-315199. [Epub ahead of print]

Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.
Maeda Y, Ishikawa H, Nishikawa H, Shimizu M, Kinoshita T, Ogihara R, Kitano S, Yamanaka C, Mitamura Y, Sugimoto M, Kondo M, Takamura Y, Ogata N, Ikeda T, Gomi F.
PLoS One. 2019 Dec 5;14(12):e0226118. doi: 10.1371/journal.pone.0226118.

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
Hideaki Someya, Kei Takayama, Masaru Takeuchi, Hiroshi Yokoyama, Takeshi Kimura, Masakazu Morioka, Yoshihiro Takamura, Seiji Sameshima, Tetsuo Ueda, Nahoko Ogata
, Maki Tashiro, Shigehiko Kitano, Taiji Sakamoto
Journal of Ophthalmology, Volume 2019, ‚Ï‚Ô‚ß‚Ç‚Ü‚¾

˜a•¶
Ÿ÷‰t«–Ô–Œ”—£‚ð”­Ç‚µ‚½ŒXŽÎ“û“ªÇŒóŒQ‚̈ê—á
ƒ’rƒ•ãA‰ª–{‘SOA¼‰ªr”VA•û“Þ•ÛŽq
Šá‰È—Õ°‹I—v 12Šª10† Page754-757(2019.10)

“Þ—ÇŒ§—§ˆã‰È‘åŠw•‘®•a‰@‚É‚¨‚¯‚鬎™Šá‰Èf—Â̌»‹µ
¼’q
“Þ—ÇŒ§ˆãŽt‰ïˆãŠw‰ï”N•ñ 32Šª1† Page10-14(2019.08)

ŒõŠ±Â’f‘wŒv‚É‚æ‚鉩”Á•]‰¿‚ðs‚Á‚½CHARGEÇŒóŒQ‚Ì1—á
”º—T”üŽqA¼’qA•û“Þ•ÛŽq
Šá‰È—Õ°‹I—v 12Šª6† Page457-459(2019.06)

ŽvtŠú”­ÇVogt-¬–ö-Œ´“c•a‚ɑ΂·‚é‘ŠúƒVƒNƒƒXƒ|ƒŠƒ““±“ü‚ÌŽŽ‚Ý
ˆÉ“¡—zŽq,Îì’q˜N, ¼’q, “ˆ—ΗÏ
¬Ž™‰È—Õ°@72Šª10† Page1569-1573(2019.10)


Šw‰ï
k•½¬30”N(2018”N)1ŒŽ1“ú`12ŒŽ31“úl
<‘ÛŠw‰ï>
ARVO Annual Meeting 2019i2019”N4ŒŽ28“ú`5ŒŽ2“ú@ƒoƒ“ƒN[ƒo[EƒJƒiƒ_j
wChange in 1-year visual acuity gain with age-related macular degeneration from 2006 and 2015. x
S Nishino, T Yasukawa, H Imaizumi, H Mastubara, H Ishikawa, K Kimura, H Terasaki, Y Mitamura, T Murata, M Yamashita, J Kogo, M Takeuchi, Y Takamura, T Murakami, T Sakamoto, M Ohji.

wChange of baseline visual acuity in eyes with age-related macular degeneration from 2006-2015. x
T Sawada, T Yasukawa, H Imaizumi, H Mastubara, K Kimura, H Terasaki, H Ishikawa, T Murakami, M Takeuchi, Y Mitamura, M Yamashita, Y Takamura, T Murata, J Kogo, T Sakamoto, M Ohji.

wRisk and Prognostic Factors of Neovascular Glaucoma After 25-gage Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.x
K Takayama, H Someya, H Yokoyama, Y Takamura, M Morioka, S Sameshima, T Ueda, S Kitano, M Tashiro, M Sugimoto, M Kondo, T Sakamoto, M Takeuchi.

<‘“àŠw‰ï>
‘æ123‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ïi2019”N4ŒŽ18“ú`21“ú@ç‘ã“c‹æE“Œ‹žj
wƒ|ƒŠ[ƒv ó–¬—–ŒŒŒŠÇÇ‚É‚¨‚¯‚é–¬—–ŒŠg’£ŒŒŠÇ ig pachyvesselshj‚ÌŒŸ“¢x
ˆÉW‰@M•vAŽR‰º^—ŽqA•½ˆäG¹A’†”ödÆAŽ¡‘ºŠ°MA‰v“c®“TAã“c“N¶A•û“Þ•ÛŽq

w—ΓàádÇ“x‚Æ”F’m‹@”\áŠQ‚ÌŠÖ˜Ax
‹g싧éA‘å—ÑŒ«ŽjA‹{“cŠì”üŒbA²”ŒŒ\ŒáA•û“Þ•ÛŽq

w–¢nŽ™–Ô–ŒÇŠù‰Ç—á‚̬Ž™Šú–¬—–Œ\‘¢x
¼’qA¼ì—ÇŽqA–Ø‘º’¼Ž÷AŒÜ–¡•¶AŽl‹{‰Á—eAŽO“c‘º‰À“TA•û“Þ•ÛŽq

wƒAƒ~ƒƒCƒhƒÀ”Z“x•Ï‰»‚É‚æ‚éÅI“œ‰»ŽY•¨Žó—e‘ÌiRAGEj‚ð‰î‚µ‚½–Ô–ŒF‘fã”ç‘B§Œäx
’Ò’†‘å¶A‰v“c®“TA•½ˆäG¹AŽR‰º^—ŽqAã“c“N¶A•û“Þ•ÛŽq

wŸøo«‰Á—”Á•Ï«1Œ^‚É‚¨‚¯‚é–¬—–ŒŠg’£ŒŒŠÇig pachyvesselshj‚ÌŒŸ“¢x
•½ˆäG¹AŽR‰º^—ŽqAˆÉW‰@M•vA’†”ödÆAŽ¡‘ºŠ°MAã“c“N¶A•û“Þ•ÛŽq
y‘æ72‰ñ“ú–{—Õ°Šá‰ÈŠw‰ïŠwp“WŽ¦—DG܉‰‘èz
w“Þ—ÇŒ§—§ˆã‰È‘åŠw•‘®•a‰@‚É‚¨‚¯‚éÅ‹ß3”NŠÔ‚Ì–¢nŽ™–Ô–ŒÇ‚Ì”­Ç‚È‚ç‚Ñ‚ÉŽ¡—Ãó‹µx
¼’qA¼ì—ÇŽqA…àV—T‘¾˜YA•õ³ŽuA‘åŒFNOA•û“Þ•ÛŽq

y‘æ72‰ñ“ú–{—Õ°Šá‰ÈŠw‰ïŠwp“WŽ¦—DG܉‰‘èz
w—ΓàኳŽÒ‚É‚¨‚¯‚é“_Šá’·ŠúŽg—p‚ÆŠááٔ畆‰Š‚Æ‚ÌŠÖ˜Ax
‹{“c‹G”üŒbA‹g싧éA¬ì_•½A³”©ç‰ÄA•û“Þ•ÛŽq

‘æ75‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ïE‘æ44‰ñ“ú–{¬Ž™Šw‰ï‘‰ï
i2019”N6ŒŽ14“ú`15“ú@•l¼ŽsEɪŒ§j
w‘Šú‚ɃVƒNƒƒXƒ|ƒŠƒ““±“ü‚ðs‚Á‚½ŽvtŠú”­ÇVogt-¬–ö-Œ´“c•a‚Ì1—áx
“¡Œ´Ž•FA¼’qAˆÉ“¡—zŽqAÎì’q˜NA“ˆ—ΗÏA•û“Þ•ÛŽq

“ú–{‡–°Šw‰ï‘æ44‰ñ’èŠúŠwpW‰ïi2019”N6ŒŽ27“ú`28“ú@–¼ŒÃ‰®ŽsEˆ¤’mŒ§j
w—Γàá«Ž‹_Œo“û“ª‚Ƈ–°‚ÌŽ¿‚ÌŠÖ˜AF•½é‹žƒXƒ^ƒfƒBc’f•ªÍx
‹{“c‹G”üŒbA‘å—ÑŒ«ŽjA‹g싧éAŽRã—D‹IAã“c“N¶AŽÔ’J“T’jA²”ŒŒ\ŒáA•û“Þ•ÛŽq

‘æ36‰ñ“ú–{ŠázŠÂŠw‰ïi2019”N7ŒŽ19“ú`20“ú@ŽD–yŽsE–kŠC“¹j
ƒVƒ“ƒ|ƒWƒEƒ€ –Ô–¬—–ŒzŠÂupdatewŽ‹‹@”\‚Æ–¬—–Œx
¼’q

‘æ58‰ñ“ú–{”’“àáŠw‰ï‘‰ï^‘æ45‰ñ…»‘ÌŒ¤‹†‰ï
i2019”N7ŒŽ19“ú`20“ú@˜a‰ÌŽRŽsE˜a‰ÌŽRŒ§j
w”’“àá‚Æ“®–¬d‰»U‹»‚ÌŠÖ˜AF•½é‹žƒXƒ^ƒfƒBc’f‰ðÍx
‹g싧éA‘å—ÑŒ«ŽjA‹{“c‹G”üŒbA²”ŒŒ\ŒáA•û“Þ•ÛŽq

‘æ73‰ñ“ú–{—Õ°Šá‰ÈŠw‰ïi2019”N10ŒŽ24“ú`27“ú@‹ž“sŽsE‹ž“s•{j
w‰fŽž‚ÉŒõŠo‚È‚µ‚Å‚ ‚Á‚½ŠJ•ú«ŠáŠOŠá‚ÌŽ‹—Í—\Œã‚Æ—Õ°“I“Á’¥x
—Ñ–¾OAXìãÄ•½A‰ª–{ŽjŽ÷A’––{®‹BAÎì—TlAã“c“N¶Aâ–{‘דñA™’J˜a•FAàV“cCAX–çA‚‘º‰ÀOA‘厭“N˜Y

w”’“àáŽèp‚ªƒƒ‰ƒgƒjƒ“•ª”呉Á‚É‹y‚Ú‚·‰e‹¿‚ÉŠÖ‚·‚é–³ìˆ×‰»”äŠrŽŽŒ±x
¼’qA²”ŒŒ\ŒáA‹{“c‹G”üŒbA‹g싧éAã“c“N¶AŽÔ’J“T’jA‘å—ÑŒ«ŽjA•û“Þ•ÛŽq

wDecreased melatonin secretion in severe glaucoma patientsx
Tadanobu YoshikawaAKenji ObayashiAKimie MiyataAKeigo SasakiANahoko Ogata

‘æ58‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ïi2019”N12ŒŽ6“ú`8“ú@’·èŽsE’·èŒ§j
wPachyvessel‚Ì—L–³‚É‚æ‚éƒ|ƒŠ[ƒvó–¬—–ŒŒŒŠÇÇÇ—á‚Ì1”NŒo‰ß‚Ì‘Šˆáx
“¡Œ´Ž•FA’Ò’†‘å¶A•½ˆäG¹AŽ¡‘ºŠ°MAŽR‰º^—ŽqA•û“Þ•ÛŽq

wpachychoroid neovasculopathy‚ÆŸøoŒ^‰Á—”Á•Ï«‚É‚¨‚¯‚錌Ÿ÷von WillebrandˆöŽqx
•½ˆäG¹AŽR‰º^—ŽqAã“c“N¶A•û“Þ•ÛŽq

w‘B“œ”A•a–Ô–ŒÇ‚ɇ•¹‚µ‚½Œ¡ˆø«–Ô–Œ”—£‚ɑ΂·‚é‹É¬ØŠJÉŽq‘ÌŽèp‚ÌpŒãŽ‹—Í‚ð—\‘ª‚·‚éˆöŽqF‘½Ž{݇“¯Œ¤‹†x
‚ŽRŒ\Aõ’JG•jA’|“à‘åA‰¡ŽROA–Ø‘º„A‚‘º‰ÀOAX‰ª³˜aAŽL“‡½Ž¡Aâ–{‘דñAã“c“N¶A–k–쎠•FA™–{¹•FA‹ß“¡•ô¶

‡“¯ŠJÃThe 4th Japan-Taiwan Vitreoretinal Joint Meeting
wEffect of optical correction on choroidal structure in children with amblyopiax
¼’q

<’n•û‰ï>
‘æ17‰ñ“Þ—ÇŒ§Šá‰È–œ—tƒtƒH[ƒ‰ƒ€i2019”N6ŒŽ1“ú@Š€Œ´ŽsE“Þ—ÇŒ§j
w—ΓàႪ‚à‚½‚ç‚·¶‘̃ŠƒYƒ€‚ւ̉e‹¿x
‹g싧é

‘æ125‰ñ‹ž“sŠá‰ÈŠw‰ïi2019”N6ŒŽ9“ú@‹ž“sŽsE‹ž“s•{j
h‘è•ñw¬Ž™Šá‰Èf—Âɂ¨‚¯‚éOCT‚Ì–ðŠ„x
¼’q

‘æ35‰ñ‘啪‘åŠwŠá‰ÈŒ¤‹†‰ïi2019”N3ŒŽ16“ú@‘啪ŽsE‘啪Œ§j
wŠá‚©‚çƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOx
•û“Þ•ÛŽq

<Œ¤‹†‰ï>
‘æ10‰ñŽáŽRŠáŽ¾Š³Œ¤‹†‰ïi2019”N6ŒŽ6“ú@˜a‰ÌŽRŽsE˜a‰ÌŽRŒ§j
w—ΓàႪ‚à‚½‚ç‚· ¶‘̃ŠƒYƒ€‚ւ̉e‹¿x
‹g싧é

YOKOHAMA Update Seminar 2019i2019”N6ŒŽ14“ú@‰¡•lŽsE_“Þ쌧j
w“œ”A•a‰©”Á•‚ŽîŽ¡—Âðl‚¦‚éx
•û“Þ•ÛŽq

‘æ11‰ñRETINAƒtƒH[ƒ‰ƒ€ in “Þ—Çi2019”N6ŒŽ21“ú@Š€Œ´ŽsE“Þ—ÇŒ§j
w–Ô–ŒŒŒŠÇ‚ɑ΂·‚éƒgƒ‰ƒ“ƒXƒŒ[ƒVƒ‡ƒiƒ‹ƒŠƒT[ƒ`x
’Ò’†‘å¶

‘æ5‰ñ“Þ—ÇŒ§_ŒoŠá‰ÈƒZƒ~ƒi[i2019”N7ŒŽ25“ú@“Þ—ÇŽsE“Þ—ÇŒ§j
wŽ‹–ì‚ÉŠÖ‚·‚éǗጟ“¢x
¼’q
Japan Macular Club 2019i2019”N8ŒŽ24“ú@Š—ŒSŽsEˆ¤’mŒ§j
w–Ô–Œ‚Å“ú“àƒŠƒYƒ€Ix
•û“Þ•ÛŽq

NOSC‚̉ïi2019”N9ŒŽ26“ú@“Þ—ÇŽsE“Þ—ÇŒ§j
wRVGEF‚Ìæ‚Öx
’Ò’†‘å¶

‘æ3‰ñ˜AŒg“o˜^ˆã‚̂‚ǂ¢i2019”N11ŒŽ2“ú@Š€Œ´ŽsE“Þ—ÇŒ§j
wŠá‚©‚çƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOx
•û“Þ•ÛŽq

Novartis Pharma Web Symposiumi2019”N11ŒŽ7“ú@Š€Œ´ŽsE“Þ—ÇŒ§j
w“ޗLjã‘å‚É‚¨‚¯‚éDME‚ÌŽ¡—Ãx
ã“c“N¶
wDME‚ÌÅ“K‚ÈŽ¡—Âðl‚¦‚éx
•û“Þ•ÛŽq
‘æ27‰ñ“Þ—ÇŒ§‰©”ÁŽ¾Š³Œ¤‹†‰ïi2019”N12ŒŽ12“ú@“Þ—ÇŽsE“Þ—ÇŒ§j
wPachychoroid neovasculopathy‚ÆŸøoŒ^‰Á—”Á•Ï«‚É‚¨‚¯‚錌Ÿ÷von WillebrandˆöŽqx
•½ˆäG¹AŽR‰º^—ŽqAã“c“N¶A•û“Þ•ÛŽqA¼–{‰ë‘¥

‘æ9‰ñŽžŠÔ‰uŠwŒ¤‹†‰ïi2019”N12ŒŽ14“ú@Š€Œ´ŽsE“Þ—ÇŒ§j
—ΓàኳŽÒ‚̊ሳƒŠƒYƒ€FLIGHTƒXƒ^ƒfƒB
‹g싧éA‘å—ÑŒ«ŽjA‹{“c‹G”üŒbA²”ŒŒ\ŒáA•û“Þ•ÛŽq


‘æ2‰ñ“Œ‹žŠá‰ÈƒTƒ~ƒbƒg2019i2019”N3ŒŽ17“ú@’†‰›‹æE“Œ‹ž“sj
wŠá‚©‚çƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO@“¡Œ´‹žƒXƒ^ƒfƒB/•½é‹žƒXƒ^ƒfƒB‚©‚çx
•û“Þ•ÛŽq

—ߘaŒ³”N“x‹ß‹EŠá‰Èˆã‰ï˜A‡‰ÄŠúuK‰ïi2019”N8ŒŽ25“ú@“Þ—ÇŽsE“Þ—ÇŒ§j
w”’“àá‚Æ”F’mÇ^¶‘̃ŠƒYƒ€x
•û“Þ•ÛŽq

<Œ¤‹†Ž‘‹à>
•¶•”‰ÈŠwÈ@Šî”ÕŒ¤‹†iCj
Šá‚̉Á—ω»‚Æ‘SgˆöŽqA¶ŠˆŠÂ‹«AQOL
Œ¤‹†ŠúŠÔF2018-04-01 – 2021-03-31
2019”N“xF1,560ç‰~ (’¼ÚŒo”ï : 1,200ç‰~AŠÔÚŒo”ï : 360ç‰~)
•û“Þ•ÛŽq

•¶•”‰ÈŠwÈ@Šî”ÕŒ¤‹†iCj
—ΓàႪ¶‘̃ŠƒYƒ€‚Ö—^‚¦‚é‰e‹¿‚ÌŒŸ“¢
Œ¤‹†ŠúŠÔF2019-04-01 – 2022-03-31
2019”N“xF1,560ç‰~ (’¼ÚŒo”ï: 1,200ç‰~AŠÔÚŒo”ï: 360ç‰~)
‹g싧é
•¶•”‰ÈŠwÈ@ŽáŽèŒ¤‹†iBj
‘Šú—Γàá‚ƶ‘̃ŠƒYƒ€‚ÉŠÖ‚·‚é‘å‹K–̓Rƒz[ƒg
Œ¤‹†ŠúŠÔF2017-04-01 – 2020-03-31
2019”N“xF1,300ç‰~ (’¼ÚŒo”ï : 1,000ç‰~AŠÔÚŒo”ï : 300ç‰~)
‹{“c‹G”üŒb

Œö‰và’c–@l‘åãƒRƒ~ƒ…ƒjƒeƒBà’c•¬Ž–‹Æ
—ΓàႪ¶‘̃ŠƒYƒ€‚É‹y‚Ú‚·‰e‹¿|‘OŒü‚«ƒRƒz[ƒgŒ¤‹†ƒx[ƒXƒ‰ƒCƒ“‰¡’f‰ðÍ|
2019”N“xF200,000‰~
‹g싧é
ˆê”Êà’c–@l“¡ˆäߘY‹L”O‘åãŠî‘bˆãŠwŒ¤‹†§—ã‰ïŒ¤‹†•¬‹à
—ΓàႪ¶‘̃ŠƒYƒ€‚Ö—^‚¦‚é‰e‹¿‚̉ð–¾
2019”N“xF2,000,000‰~
‹g싧é

<ŽóÜ>
2019”N Outstanding Research AwardiŽžŠÔ‰uŠwŒ¤‹†‰ïj
‹g싧é